METTL4 and neoplasm: These findings demonstrate that hypoxia/METTL4-mediated nuclear 6mA depositions induce tumor metastasis through activating multiple metastasis-inducing genes, identifying METTL4 as a therapeutic target for hypoxia-involved tumors.